CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...

Lupus is a debilitating auto-immune disease affecting about 1.5 million Americans. New research shows a therapy that's been used for cancer patients for years is also helping those with Lupus. Lupus ...

ORLANDO, Fla. - Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with lupus ...

INDIANAPOLIS (WISH) — Lupus is a debilitating autoimmune disease that affects around 1.5 million Americans. Now, new research shows a therapy that’s been used for cancer patients may help people with ...

Kathleen Ford of Solano County was a nurse for more than 20 years, until one day she squatted down to help a patient and, hobbled by terrible joint pain, couldn’t stand up. Then in her 60s, Ford had ...

UCI Health has opened a clinical trial to test an investigational cell therapy for lupus with the potential to give patients long-term remission of symptoms. One of the first California participants, ...

Ruth Wilson has lupus, nicknamed the disease of 1,000 faces for its variety of symptoms. Her journey offers a snapshot of the dark side of the immune system. Lupus is one of a rogues’ gallery of ...

On the heels of last week’s lupus nephritis nod from the FDA, Roche’s Gazyva is proving once again that it still has new tricks despite its 12 years on the market—and not just in its original oncology ...

Eventual tapering and withdrawal of steroids in patients with lupus nephritis is recommended to minimize the drugs' adverse effects, but the ideal timing is uncertain. This study followed 136 lupus ...